Zdrowie i gospodarka · 27/03/2002

FDA Announces Submission of Information Collection for Fast Track Drug Development Programs

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to fast track drug development programs, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.